Skip to main content
Indegene Limited logo

Indegene Limited — Investor Relations & Filings

Ticker · INDGN ISIN · INE065X01017 LEI · 335800XFEREFIW9LG995 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 290 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country IN India
Listing BSE.NS INDGN

About Indegene Limited

https://www.indegene.com/

Indegene Limited provides digital-led commercialization services for the life sciences sector. The company integrates deep domain knowledge with proprietary technology platforms to assist biopharmaceutical, emerging biotech, and medical device organizations. Its core offerings span the entire product lifecycle, including clinical development support, regulatory compliance, pharmacovigilance, and multi-channel marketing operations. By leveraging artificial intelligence and machine learning, Indegene enables clients to optimize drug development processes, enhance patient engagement, and drive operational efficiencies. The company focuses on modernizing traditional commercial models through data-driven insights and digital transformation strategies, helping global healthcare organizations navigate complex regulatory environments and improve health outcomes through scaled, technology-enabled solutions.

Recent filings

Filing Released Lang Actions
Intimation of Investors / Analysts Meeting
Regulatory Filings Classification · 85% confidence The document is an intimation to stock exchanges under SEBI’s Listing Obligations & Disclosure Requirements regarding the schedule of investor/analyst meetings. It does not contain financial statements, results, or minutes of meetings; rather, it is a regulatory announcement of planned meetings. This falls under the general regulatory filings category.
2026-05-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is a statutory disclosure under SEBI (Listing Obligations and Disclosure Requirements) Regulations informing stock exchanges of the schedule for upcoming investors/analysts meetings. It does not contain financial results, a report, or a formal presentation, nor does it fit specific categories like earnings release, proxy materials, or capital changes. It is a general regulatory announcement, making Regulatory Filings (RNS) the appropriate classification.
2026-05-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of a conference call discussing the financial results for the quarter and year ended March 31, 2026. It includes management commentary, financial highlights, strategic progress, customer portfolio performance, and AI-led innovation wins. The text explicitly mentions it is a transcript of the earnings conference call held on April 30, 2026, and includes Q&A format elements typical of call transcripts. It references the earnings release and investor presentation but is itself the full transcript of the call. Therefore, the document fits the category of a Call Transcript (CT).
2026-05-06 English
Action(s) initiated or orders passed
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to timely reporting of material events or information by listed companies. It details receipt of a final assessment order from the Income Tax Department with a tax demand and the company's response plans. The document is an announcement of a regulatory event affecting the company, not a financial report, audit report, or earnings release. It is relatively short (3798 characters) and serves as a regulatory update rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-05-05 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Indegene has been identified as a leader in a specific ISG Provider Lens report for 2026. It is addressed to stock exchanges pursuant to SEBI regulations and includes a summary of the recognition and company statements. There are no financial statements, detailed financial data, or regulatory filings such as annual or quarterly reports. The document is not a report itself but an announcement of an external recognition. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is a public announcement related to company recognition and market positioning, which is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not fit other specific categories.
2026-05-04 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the publication of a newspaper advertisement of financial results for the quarter and year ended March 31, 2026. It references Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of financial results via newspaper advertisements. The document states that the advertisement has been published and is enclosed, and that the information will also be posted on the company's website. The document length is only 2466 characters, which is quite short and does not contain actual financial statements or detailed financial data. It is essentially an announcement of the publication of financial results, not the financial results report itself. According to the "Menu vs Meal" rule, such a document is classified as a Report Publication Announcement (RPA) rather than an Annual Report (10-K) or Interim Report (IR). Therefore, the appropriate classification is RPA with high confidence.
2026-05-01 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.